Cargando…
A novel intraperitoneal therapy for gastric cancer with DFP‐10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model
PURPOSE: In advanced gastric cancer, peritoneal dissemination is a life‐threatening mode of metastasis. Since the treatment options with conventional chemotherapy remain limited, any novel therapeutic strategy that could control such metastasis would improve the outcome of treatment. We recently dev...
Autores principales: | Ando, Hidenori, Fukushima, Masakazu, Eshima, Kiyoshi, Hasui, Taichi, Shimizu, Taro, Ishima, Yu, Huang, Cheng‐Long, Wada, Hiromi, Ishida, Tatsuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885878/ https://www.ncbi.nlm.nih.gov/pubmed/31609087 http://dx.doi.org/10.1002/cam4.2598 |
Ejemplares similares
-
Anticancer activity of the intraperitoneal-delivered DFP-10825, the cationic liposome-conjugated RNAi molecule targeting thymidylate synthase, on peritoneal disseminated ovarian cancer xenograft model
por: Iizuka, Kenzo, et al.
Publicado: (2018) -
Development of new promising antimetabolite, DFP-11207 with self-controlled toxicity in rodents
por: Fukushima, Masakazu, et al.
Publicado: (2017) -
A novel polyethylene glycol (PEG)‐drug conjugate of Venetoclax, a Bcl‐2 inhibitor, for treatment of acute myeloid leukemia (AML)
por: Ando, Hidenori, et al.
Publicado: (2021) -
Doxorubicin Embedded into Nanofibrillated Bacterial Cellulose (NFBC) Produces a Promising Therapeutic Outcome for Peritoneally Metastatic Gastric Cancer in Mice Models via Intraperitoneal Direct Injection
por: Ando, Hidenori, et al.
Publicado: (2021) -
Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil(®)) in C26 Tumor-Bearing Immunocompetent Mice
por: Takayama, Takuma, et al.
Publicado: (2020)